Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
Lack of health insurance amongst population especially within the developing countries or lack of insurance covering all types of IOLs or contact lens in developed countries is a significant challenge faced by the ophthalmology industry. The other challenges include low awareness about the ophthalmic disorders, especially in developing countries. This is primarily due to the lack of awareness amongst rural population about the various ophthalmic disorders such as cataract.
The ophthalmology drugs market is classified based on the type of drugs; treatment based drugs, over the counter drugs and ocular anesthetics. Ocular anesthetics are administered by surgeons during surgery and can not be bought by individuals. The treatment based drugs are provided based on the diagnosed conditions and are classified as dry eye drugs, retinal disorder drugs, anti-allergy/inflammatory/infective drugs and anti-glaucoma drugs. Over the counter drugs can be procured without any need of a prescription. This report analyses drugs and devices in the ophthalmology market along with its sub-segments for their revenues, key growth drivers and opportunities.
The Global Ophthalmology Drug and Devices Market is expected to reach a market size of $36 billion by the year 2014, at a CAGR of 5.4% from 2009-2014. The drugs market is expected to reach a size of $19.8 billion by the year 2014 growing at a CAGR of 4% from 2009-2014.
Market estimates and forecast
The report provides in-depth market estimates and forecast for ophthalmology devices based on major eye disorders such as cataract, refractive error and other retinal disorders. It segments the global ophthalmology drugs market on the basis of treatment based drugs, OTC drugs and anesthetics.
What makes our reports unique?
- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- 15 pages of high level analysis including benchmarking strategies, best practices and the markets cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
Powerful Research and Analysis
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
Table of contents
Executive summary
Market overview
Market dynamics
Cataract market
Refractive error market
Other retinal disorders
Global ophthalmology drugs market
Drug delivery types
Geographic analysis
Competitive landscape
Patent analysis
definitions
1 introduction
1.1 Key take-aways
1.2 Report description
1.3 Markets covered
1.4 Research methodology
1.5 stakeholders
2 Summary
3 Market overview
3.1 Market Overview
3.2 Market Analysis
3.3 Market challenges
3.4 Market opportunities
3.5 Competitive landscape
3.6 Patent trends
3.7 Driving factor analysis of ophthalmology market
3.7.1 Demand side drivers
3.7.2 Supply side drivers
3.7.3 Restraints
3.7.4 Opportunities
3.7.5 Key competitive points
4 Market dynamics
4.1 Drivers
4.1.1 global increase in ageing population
4.1.2 technology developments
4.1.3 New OPHTHALMIC treatments
4.2 Restraints & OPPORTUNITIES
4.2.1 Affordability
4.2.2 Growth potential in developing countries
5 Cataract market
5.1 Introduction
5.2 Cataract solutions
5.3 Market potential
5.4 Future outlook
5.5 Drivers, restraints, & opportunities
5.5.1 Cataract backlog shows huge potential
5.5.2 High surgery cost
5.5.3 Low penetration in developing countries
5.6 TECHNOLOGY TRENDS
5.6.1 Femtosecond lasers
5.6.2 Use of Multifocal implant
5.6.3 Other technology developments
5.7 Intraocular Lens Market
5.7.1 Introduction
5.7.2 Drivers, restraints, & opportunities
5.7.2.1 Advancements in technologies
5.7.2.2 High cost of IOLs
5.7.2.3 Phakic IOLs
5.7.3 TECHNOLOGY TRENDS
5.7.3.1 Implant edge design
5.7.3.2 Accommodating implants
5.7.3.3 Implants that correct optical aberrations
5.8 Phacoemulsification devices
5.8.1 Introduction
5.8.2 Drivers & Restraints
5.8.2.1 Increased consumer preference due to reduced risk
5.8.2.2 High cost of phacoemulsification systems
5.8.2.3 Lack of trained ophthalmologists
5.8.3 Opportunities
5.8.3.1 Bimanual phacoemulsification systems
5.8.3.2 Reduced intraocular pressure
5.8.4 TECHNOLOGY TRENDS
6 Refractive Error
6.1 Introduction
6.2 Refractive error solutions
6.3 Market Potential
6.4 Future outlook
6.5 Drivers, restraints, & opportunities
6.5.1 Shift in consumer preference
6.5.2 Lack of insurance
6.5.3 Initiatives by Refractive Error Committee
6.6 TECHNOLOGY TRENDS
6.6.1 Easy diagnosis of refractive error
6.6.2 Other TECHNOLOGY TRENDS
6.7 Excimer LASer
6.7.1 Introduction
6.7.2 Drivers, restraints, & opportunities
6.7.2.1 Expansion of applications
6.7.2.2 Long term effects of LASIK cannot be determined
6.7.2.3 High Initial Investment in LASIK Equipment
6.7.2.4 Potential among Generation Y
6.7.3 TECHNOLOGY TRENDS
6.7.3.1 Wavefront LASIK eye surgery
6.7.3.2 Laser Assisted Sub-Epithelial Keratomileusis
6.8 Contact lens
6.8.1 Introduction
6.8.2 Drivers & restraints
6.8.2.1 Increased comfort
6.8.2.2 High cost of maintenance while using contact lens
6.8.2.3 Risks associated with the usage of contact lens
6.8.3 Opportunities
6.8.3.1 Bionic contact lens
6.8.3.2 Use of lenses while sleeping
6.8.4 TECHNOLOGY TRENDS
6.8.4.1 Gas permeable contact lenses
7 Other retinal disorders
7.1 Introduction
7.2 Drivers & opportunities
7.2.1 Increase in diabetic retinopathy
7.2.2 Shift from 25 g to 23 g
8 Global ophthalmology drugs market
8.1 Treatment based ophthalmology drugs
8.1.1 Dry eye drugs
8.1.1.1 Restasis
8.1.1.1.1 Drivers & Restraints
8.1.1.2 Hyalein
8.1.2 Retinal disorders
8.1.2.1 Lucentis
8.1.2.2 Visudyne
8.1.2.3 Bevacizumab
8.1.3 Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs
8.1.3.1 Patanol/Opatanol/Pataday
8.1.3.2 TobraDex
8.1.3.3 Vigamox/Vegamox
8.1.4 Anti-glaucoma drugs market
8.1.4.1 Drivers and Restraints
8.1.4.1.1 Increased prevalence of glaucoma
8.1.4.1.2 Increasing number of generics & no new products launches
8.1.4.2 Xalatan/xalacom
8.1.4.3 Cosopt/Trusopt
8.1.4.4 Travatan/Travatanz/Duotrav
8.1.4.5 Lumigan/ganfort
8.1.4.6 Alphagan/Combigan
8.1.4.7 Azopt
8.2 Over the counter ophthalmology drugs
8.2.1 Drivers
8.2.1.1 Increasing awareness & shifting trend towards self medication
8.2.1.2 Relaxation in OTC laws
8.2.2 Restraints
8.2.2.1 Safety concerns
8.3 Ocular anesthetics
8.3.1 Drivers and restraints
8.3.1.1 Increased product safety and efficacy
8.3.1.2 Increasing incidences of eye disorders
8.3.1.3 Products do not suit all patients needing eye surgery
9 Drug delivery types
9.1 Capsules & Tablets
9.2 Gels
9.3 eye drops
9.4 Eye ointment
9.5 Eye Solutions
10 Geographic analysis
10.1 Introduction
10.2 U.S. Ophthalmology devices market
10.3 Europe ophthalmology devices market
10.4 Asia ophthalmology devices market
10.5 ROW ophthalmology devices market
10.6 U.S opthalmologic drugs market
10.7 Europe opthalmologic drugs market
10.8 Asia opthalmologic drugs market
10.9 ROW opthalmologic drugs market
11 Competitive Landscape
11.1 Introduction
11.2 New products analysis
12 Patent Analysis
12.1 Patent growth analysis for ophtholmology devices
12.2 patent analysis for devices by Geography
12.3 Patent analysis for devices by assignees
12.4 Patent analysis for ophthalmology drugs
13 Company Profiles
13.1 Abbott Medical Optics, Inc.
13.2 Acucela Inc
13.3 Akorn Inc
13.4 Alcon Inc.
13.5 Alimera Sciences, Inc.
13.6 Allergan, Inc.
13.7 Appasamy Associates
13.8 Aurolab
13.9 Bausch & Lomb Inc.
13.10 Canadian Bio Med Systems Inc
13.11 Carl-Zeiss AG
13.12 CIBA Vision Corp. (novartis)
13.13 Danube Pharmaceuticals
13.14 Ellex Medical Lasers Ltd
13.15 Essilor International S.A.
13.16 Haag-Streit AG
13.17 Hoya Corp.
13.18 Inspire Pharmaceuticals Inc
13.19 ISTA Pharmaceutical
13.20 Johnson & Johnson Vision Care, Inc.
13.21 Menicon Co., Ltd
13.22 Merck & Co., Inc
13.23 Mimetogen Pharmaceuticals Inc
13.24 Novagali Pharma S A
13.25 NIDEK CO., LTD
13.26 Novagali Pharma S A
13.27 Oertli Instrument AG
13.28 Opko Health Inc
13.29 Pfizer Inc
13.30 QLT Inc.
13.31 Rayner Intraocular Lenses Ltd
13.32 Roche Holding Ltd
13.33 Santen Pharmaceutical Co., Ltd
13.34 STAAR Surgical Company
13.35 Technolas Perfect Vision GmbH
13.36 Ziemer Ophthalmic Systems AG
Appendix
U.S. Patents
Europe Patents
Japan Patents
List of TableS
Table 1 Global ophthalmology drugs and devices market, 2009 2014 ($Millions)
Table 2 Cataract devices market, by products 2007 2009 ($Millions)
Table 3 Cataract devices market, by geography 2007 2009 ($Millions)
Table 4 Intraocular lens market, by geography 2007 2009 ($Millions)
Table 5 Phacoemulsification device market, by geography 2007 2009 ($Millions)
Table 6 refractive error devices market, y products 2007 2009 ($Millions)
Table 7 refractive error devices market, by geography 2007 2009 ($Millions)
Table 8 Excimer laser market, by geography 2007 2009 ($Millions)
Table 9 Contact lens market, by geography 2007 2009 ($Millions)
Table 10 vitrectomy systems market, by geography 2007 2009 ($Millions)
table 11 Global ophthalmology drugs market, by products 2007-2014 ($million)
table 12 Global ophthalmology drugs market, by geography 2007-2014 ($million)
table 13 Global Treatment based ophthalmology drugs market, by products 2007-2014 ($million)
table 14 Global Treatment based ophthalmology drugs market, by geography 2007-2014 ($million)
table 15 Global dry eye drugs market, by products 2007-2014 ($million)
table 16 Global dry eye drugs market, by geography 2007-2014 ($million)
table 17 Global restasis market, by geography 2007-2014 ($million)
table 18 Global hyalein market, by geography 2007-2014 ($million)
table 19 Global retinal disorders market, by products 2007-2014 ($million)
table 20 Global retinal disorders market, by geography 2007-2014 ($million)
table 21 Global lucentis market, by geography 2007-2014 ($million)
table 22 Global Visudyne market, by geography 2007-2014 ($million)
table 23 Global Bevacizumab market, by geography 2007-2014 ($million)
table 24 Global Ophthalmic Anti-Allergy/ Inflammatory/ Infective Drugs market, by products 2007-2014 ($million)
table 25 Global Ophthalmic Anti-Allergy/ Inflammatory/ Infective Drugs market, by geography 2007-2014 ($million)
table 26 Global Patanol/Opatanol/Pataday market, by geography 2007-2014 ($million)
table 27 Global TobraDex market, by geography 2007-2014 ($million)
table 28 Global Vigamox/Vegamox market, by geography 2007-2014 ($million)
table 29 Global Antiglaucoma drugs market, by products 007-2014 ($million)
table 30 Global Antiglaucoma drugs market, by geography 2007-2014 ($million)
table 31 Global Xalatan/xalacom market, by geography 2007-2014 ($million)
table 32 Global Cosopt/Trusopt market, by geography 2007-2014 ($million)
table 33 Global Travatan/Travatanz/Duotrav market, by geography 2007-2014 ($million)
table 34 Global Lumigan/ganfort market, by geography 2007-2014 ($million)
table 35 Global Alphagan/combigan market, by geography 2007-2014 ($million)
table 36 Global Azopt market, by geography 2007-2014 ($million)
Table 37 Global otc drugs market, by geography 2007-2014 ($million)
Table 38 Global ocular anesthetics market, by geography 2007-2014 ($million)
Table 39 Global ophthalmology devices market, by geography 2007 2014 ($Millions)
Table 40 U.s. ophthalmology devices market, by products 2007 2014 ($Millions)
Table 41 Europe ophthalmology devices market, by products 2007 2014 ($Millions)
Table 42 asia ophthalmology devices market, by products 2007 2014 ($Millions)
Table 43 row ophthalmology devices market, by products 2007 2014 ($Millions)
Table 44 Global Opthalmologic Drugs Market, By Geography 2007-2014 ($Million)
Table 45 U.S Opthalmologic Drugs Market, By Products 2007-2014 ($Million)
Table 46 European Opthalmologic Drugs Market, By Products 2007-2014 ($Million)
Table 47 Asian Opthalmologic Drugs Market, By Products 2007-2014 ($Million)
Table 48 ROW Opthalmologic Drugs Market, By Products 2007-2014 ($Million)
Table 49 New product launch/ Approval (Drugs) (2007-April 2010)
Table 50 Agreements and collaborations (Drugs) (2007-May 2010)
Table 51 Mergers and acquisitions (drugs) (2008 - Mar 2010)
TABLE 52 Agreements & Collaborations (Devices) (January 2007 March 2010)
TABLE 53 Mergers & Acquisitions (January 2007 March 2010)
TABLE 54 New Product Development and R&D (January 2007 March 2010)
List of FIGURES
Figure 1 Market segmentation
Figure 2 ophthalmology devices: market segments
Figure 3 Ophthalmology devices: Market Dynamics
Figure 4 Ophthalmology devices: market challenges
Figure 5 Ophthalmology devices: market opportunities
Figure 6 Global ophthalmology market: competitive landscape
Figure 7 Ophthalmology devices: Patent trends (2004 - 2009)
Figure 8 Driving factor analysis of ophthalmology market
Figure 9 Relative positioning of ophthalmology drugs (2009)
Figure 10 Middle year population in less developed countries
Figure 11 Middle year population in more developed countries
Figure 12 Major causes of blindness
Figure 13 Market shares of IOL players (2007)
Figure 14 Market shares of phacoemulsification device players (2007)
Figure 15 Market Shares of excimer laser players (2007)
Figure 16 Market shares of contact lens players (2007)
Figure 17 Markets shares of vitrectomy system players (2007)
Figure 18 Potential share of visual impairment causes
Figure 19 ophthalmology Devices market: growth strategies (January 2007 March 2010)
Figure 20 Segmentation of new product launches (Device) (January 2007 March 2010)
Figure 21 Ophthalmology drugs market: Growth strategies (January 2007-April 2010)
Figure 22 Year-on-year patent analysis (2007 - 2009)
Figure 23 Patent analysis, by geography (2004 - 2009)
Figure 24 Patents by assignees (2004 - 2009)
Figure 25 Patent analysis by geography (January 2004 April 2010)
Figure 26 Shift in patent trends (2005 2009)
Figure 27 PATENT ANALYSIS BY ASSIGNEES (2004-2010)
Global Ophthalmology Drugs & Devices Market to reach $36 billion by 2014
The Global Ophthalmology Drug and Devices Market report analyzes the ophthalmology drugs and devices market over the period 2009-2014. It studies the major market drivers and opportunities for the ophthalmology drugs and devices market and also evaluates the major trends in the macro- and micro-markets with respect to different geographic regions.
Global ophthalmology devices and drugs market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
Lack of health insurance amongst population especially within the developing countries or lack of insurance covering all types of IOLs or contact lens in developed countries is a significant challenge faced by the ophthalmology industry. The other challenges include low awareness about the ophthalmic disorders, especially in developing countries. This is primarily due to the lack of awareness amongst rural population about the various ophthalmic disorders such as cataract.
The ophthalmology drugs market is classified based on the type of drugs; treatment based drugs, over the counter drugs and ocular anesthetics. Ocular anesthetics are administered by surgeons during surgery and can not be bought by individuals. The treatment based drugs are provided based on the diagnosed conditions and are classified as dry eye drugs, retinal disorder drugs, anti-allergy/inflammatory/infective drugs and anti-glaucoma drugs. Over the counter drugs can be procured without any need of a prescription. This report analyses drugs and devices in the ophthalmology market along with its sub-segments for their revenues, key growth drivers and opportunities.
The global Ophthalmology Drug and Devices market is expected to reach a market size of $36 billion by the year 2014, at a CAGR of 5.4% from 2009-2014. The drugs market is expected to reach a size of $19.8 billion by the year 2014 growing at a CAGR of 4% from 2009-2014.
